Sign In
Buy ARKG
$33.15
-0.260 (-0.778%)
At Close: Jun 08, 2026
Inside a Star Genomics ETF's Notoriety
10:29am, Friday, 30'th Oct 2020
There are multiple exchange traded funds addressing the lucrative genomics segment, but the real star of the group is the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). ARKG includes companies
Can't Get Enough Biotech Exposure in Your Portfolio?
12:38pm, Thursday, 29'th Oct 2020
As coronavirus cases start to tick upwards once more, the race to create a vaccine will only intensify, boding well for the biotechnology sector. ETF investors may want to keep an eye on biotech funds
The Most Underrated ARK ETF Is ARK Genomic Revolution Multi-Sector ETF
04:46pm, Wednesday, 28'th Oct 2020
ARK Genomic Revolution Multi-Sector ETF captures innovation in an industry that is severely under-covered relative to other ARK focused industries. Existing treatments for severe diseases are very exp
ARK Genomics Fund Poised for the Future of Healthcare
10:03am, Monday, 26'th Oct 2020
There are some investment niches where active management can benefit investors and biotechnology. Genomics is one such industry and the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) stands out
ARKG: An ETF Using Disruptive Innovation To Drive Impressive Growth
10:25pm, Wednesday, 09'th Sep 2020
The five actively managed ETFs from ARK Funds have driven impressive returns by investing in disruptive innovation.
Evogene: Hidden Gems Of Computational Predictive Biology (Part 3 Of 4) - Ag Plenus (Novel Herbicides And Pesticides)
10:48am, Wednesday, 02'nd Sep 2020
Evogene's 100% owned subsidiary AgPlenus utilizes Evogene's computational predictive biology platform to develop Ag-Chemicals (novel herbicides, insecticides and other crop control products).
3 Important Things I've Learned Reviewing ARK's ETFs
10:53am, Monday, 24'th Aug 2020
ARK Invest currently offers some of the best performing ETFs over the past five years. The five actively managed ETFs provided by ARK cover innovation, autonomous technology and robotics, next generat
Evogene: Hidden Gems Of Computational Predictive Biology, Part 2 Of 4 - Lavie Bio
10:08am, Monday, 24'th Aug 2020
Evogene's 72% owned subsidiary Lavie Bio Ltd. focuses on Microbiome based Ag-biologicals: microbial and naturally derived biostimulants and biopesticides.
New GERM ETF Launched to Tap the Growing Biotech Sector
03:10pm, Tuesday, 23'rd Jun 2020
GERM invests in the hottest emerging biotechnology trends.
Capital Planning Advisors, LLC Buys ARK Investment Management LLC - ARK Genomic Revolu, ...
12:00am, Monday, 11'th May 2020Pacific Sun Financial Corp Buys Vanguard High Dividend Yield, SPDR S&P Health Care ...
12:00am, Thursday, 07'th May 2020Concentrum Wealth Management Buys ProShares UltraPro Short S&P5……, iShares Nasdaq ...
12:00am, Monday, 04'th May 2020First-Mover Pandemic Disease Fight ETF On The Way
02:35pm, Tuesday, 28'th Apr 2020
Pacer Financial has filed for Pacer BioThreat ETF to enjoy the first-mover advantage that provide investors an option to capitalize on the new opportunities triggered by coronavirus.
